EUVIMEDEUVIMED entdecken
Open Access

Assessing heterogeneity in surrogacy using censored data

Layla Parast iD, Lu Tian iD, Tianxi Cai

Statistics in Medicine · 2024

DOI: 10.1002/sim.10122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Layla Parast und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, Texas. Hauptthemen laut MEDLINE: Biomarkers, Computer Simulation, Blood Glucose. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Determining whether a surrogate marker can be used to replace a primary outcome in a clinical study is complex. While many statistical methods have been developed to formally evaluate a surrogate marker, they generally do not provide a way to examine heterogeneity in the utility of a surrogate marker. Similar to treatment effect heterogeneity, where the effect of a treatment varies based on a patient characteristic, heterogeneity in surrogacy means that the strength or utility of the surrogate marker varies based on a patient characteristic. The few methods that have been recently developed to examine such heterogeneity cannot accommodate censored data. Studies with a censored outcome are typically the studies that could most benefit from a surrogate because the follow‐up time is often long. In this paper, we develop a robust nonparametric approach to assess heterogeneity in the utility of a surrogate marker with respect to a baseline variable in a censored time‐to‐event outcome setting. In addition, we propose and evaluate a testing procedure to formally test for heterogeneity at a single time point or across multiple time points simultaneously. Finite sample performance of our estimation and testing procedure are examined in a simulation study. We use our proposed method to investigate the complex relationship between change in fasting plasma glucose, diabetes, and sex hormones using data from the diabetes prevention program study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersComputer SimulationBlood GlucoseHumansFemaleModels, StatisticalMaleGonadal Steroid HormonesStatistics, NonparametricData Interpretation, StatisticalDiabetes Mellitus

Stichwörter der Autor:innen

biomarkernonparametricsurvivaltreatment effect

Substanzen

BiomarkersBlood GlucoseGonadal Steroid Hormones

Autor:innen und Institutionen

  • Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, Texas.
  • Department of Biomedical Data Science, Stanford University, Stanford, California.
  • Department of Biostatistics, Harvard University, Cambridge, Massachusetts.

ORCID-Profile: Layla Parast, Lu Tian

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Parast, L., Tian, L., & Cai, T. (2024). Assessing heterogeneity in surrogacy using censored data. Statistics in Medicine. https://doi.org/10.1002/sim.10122

Vancouver

Parast L, Tian L, Cai T. Assessing heterogeneity in surrogacy using censored data. Statistics in Medicine. 2024. doi:10.1002/sim.10122

BibTeX
@article{Parast2024,
  author = {Parast, Layla and Tian, Lu and Cai, Tianxi},
  title = {Assessing heterogeneity in surrogacy using censored data},
  journal = {Statistics in Medicine},
  year = {2024},
  doi = {10.1002/sim.10122}
}
Kostenlos starten →